IPO
LOGIN
OPEN A DEMAT ACCOUNT
IPO
Login
Open a
Demat
Account
HOME
ABOUT US
PRODUCTS
Equity
Currency
Commodity
IPO
Mutual Funds
PMS
SLBM
SERVICES
Investment Banking
Institutional Equities
Wealth Management
Depository
TRADE WITH SYSTEMATIX
Partner With Us
Trading Simplified
Payment Gateway
Link UPI
KYC Updation
ReKYC
(Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
Bank Details
Account Opening Process
Incapacitated investor
RESEARCH
MARKETS
Overview
Equity
Derivatives
IPO
Mutual Funds
Commodity
Currency
Company Info
INVESTORS
Investor Login
Investor Relations
Investor Grievances
ODR
Scores
Downloads
Investor Charter
Information to Physical Shareholders
Procedure for Filing a Complaint
Investor Education
CONTACT US
Our Reach
Careers
OPEN A DEMAT ACCOUNT
HOME
ABOUT US
PRODUCTS
EQUITY
CURRENCY
COMMODITY
IPO
MUTUAL FUND
PMS
SLBM
SERVICES
INVESTMENT BANKING
INSTITUTIONAL EQUITIES
WEALTH MANAGEMENT
DEPOSITORY
TRADE WITH SYSTEMATIX
PARTNER WITH US
TRADING SIMPLIFIED
PAYMENT GATEWAY
LINK UPI
KYC UPDATION
ReKYC (Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
BANK DETAILS
ACCOUNT OPENING PROCESS
Incapacitated investor
RESEARCH
MARKETS
OVERVIEW
EQUITY
DERIVATIVES
IPO
MUTUAL FUND
COMMODITY
CURRENCY
COMPANY INFO
INVESTORS
INVESTOR LOGIN
INVESTOR RELATIONS
INVESTOR GRIEVANCES
ODR
SCORES
DOWNLOADS
INVESTOR CHARTER
INFORMATION TO PHYSICAL SHAREHOLDERS
PROCEDURE FOR FILING A COMPLAINT
Investor Education
CONTACT US
OUR REACH
CAREERS
Equity
Derivatives
Currency
Mutual Fund
IPO Analysis
Daily Market Tracker
Gainers & Losers
Value & Volume Toppers
52 Week Highs & Lows
New Highs & Lows
Buyers & Sellers
Out/Under Performers
Bulk Deals
Block Deals
Unusual Volume
Rising Volume
Exchange Holidays
5 Days Up & Down
Index Movers
Index Overview
Top Sectors
News & Analysis
Pre Session Commentary
Mid Session Commentary
End Session Commentary
Quick Review
Market Beat
Stock Alert
Hot Pursuit
Foreign Markets
Economy News
Corporate News
Corporate Results
Other Markets
Futures Markets
Corporate Information
Company Snapshot
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Previous Quarter Comp
Director's Report
Score Board
Mutual Fund Holdings
Announcements
Peer Comparison
Technical Chart
Corporate Actions
Announcements
Book Closure
Board Meetings
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Name Change
Split Of Face Value
Event Calendar
Other Markets
ADR Prices
FII Investments
MF Investments
Forex Details
World Indices
GDR Prices
Equity
Derivative
Currency
Commodity
Mutual Fund
IPO
Price Analysis
Volume Analysis
News Analysis
Market Option
Other Option
Company Information
Gainers & Losers
52 Week High Low
News Highs and Low
Advances & Declines
Home
Market Info
Corporate Information
Company Snapshot
Company Snapshot
BSE
Cohance Lifesciences Ltd
BSE Code
543064
ISIN Demat
INE03QK01018
Book Value (₹)
60.86
NSE Symbol
COHANCE
Div & Yield %
0
Market Cap (
₹
Cr.)
37,021.02
P/E *
104.84
EPS *
9.23
Face Value (₹)
1
* Profit to Earning Ratio
* Earning Per Share
Stock Price Details
Last Price (₹)
927.00
Change
-53.55 (-5.53%)
Best Buy (₹)
0.00
Best Sell (₹)
0.00
Today's Range
888.85 - 927.00
52-Week Range
856.90 - 1,359.00
Beta (1 Year)
0.56
Chart
1 Day
|
5 Day
|
3 Month
|
1 Year
|
5 Year
Corporate Announcements
Volumes jump at Poonawalla Fincorp Ltd counter
Cohance Lifesciences Ltd leads losers in 'A' group
Volumes spurt at Cohance Lifesciences Ltd counter
Cohance Lifesciences drops after block deal
Cohance Lifesciences Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Cohance Lifesciences Ltd - Cohance Lifesciences Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Cohance Lifesciences' Andhra Pradesh facility clears USFDA cGMP inspection with zero observations
Cohance Lifesciences' API unit 1 completes USFDA inspection
Cohance Lifesciences Ltd - Announcement under Regulation 30 (LODR)-Credit Rating
Cohance Lifesciences Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Corporate Details
Incorporation Year :
2018
Chairman :
Vivek Sharma
Ownership Group :
Indian Private
Sector :
Pharmaceuticals
Industry :
Pharmaceuticals - Indian - Bulk Drugs & Formln
Registered Office :
Cohance Lifesciences Ltd
8-2-334 SDE Serene Chambers,
3 Floor Avenue 7 Road No 5,
Hyderabad,
Telangana - 500034,
Phone : 91-40-23549414/1142/3311,
Fax : 91-40-23541152
E-Mail :
khrao@suvenpharm.com
URL :
http://www.suvenpharm.com
Investor Returns
Period
Date
Price
Returns (%)
1Week
10-Sep-2025
989.80
-2.23
1Month
18-Aug-2025
899.00
7.64
3Month
17-Jun-2025
992.55
-2.50
6Month
17-Mar-2025
1,135.75
-14.80
1Year
17-Sep-2024
1,155.70
-16.27
Mutual Funds Holding
Scheme Name
% Holding
Market Value
DSP Healthcare Fund
7.38
229.19
Invesco India Contra Fund
1.01
191.39
AXIS Small Cap Fund
0.70
178.45
DSP ELSS Tax Saver Fund
1.02
168.20
DSP Flexi Cap Fund
1.38
161.20
Peerset : Pharmaceuticals - Indian - Bulk Drugs & Formln
Company
Last Price (₹)
Change (%)
52Week High (₹)
52Week Low (₹)
Market Cap (₹ Cr.)
Sun Pharmaceutical Industries Ltd
1,648.90
1.77
1,960.20
1,555.00
395,626.34
Cipla Ltd
1,578.35
1.22
1,702.00
1,310.05
127,491.86
Dr Reddys Laboratories Ltd
1,322.45
0.88
1,404.60
1,025.90
110,372.64
Mankind Pharma Ltd
2,638.15
2.70
3,050.00
2,115.50
108,891.88
Zydus Lifesciences Ltd
1,047.90
1.26
1,111.00
797.05
105,443.26
Index Details
BSE 500, BSE HC, BSE SmallCap